ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

WSJ BLOG/Health: A.M. Vitals: Fruits, Nuts and Whole Grains Form Basis for Best Weight-Loss Diet

(This story has been posted on The Wall Street Journal Online's Health Blog at By Jonathan D. Rockoff Here's what's making health news this morning: Not All Calories Are Equal, Study Shows (WSJ): A study comparing three diets found that the best one for keeping weight off while avoiding unwanted side effects is based on healthy carbohydrates such as fruit, vegetables, nuts and whole grains. Wal-Mart Lags in Clinic Race (WSJ): Five years ago, Wal-Mart pledged to open as many as 2,000 of these clinics in its stores by this year, but it only has 149 operating in the U.S. and closed 33 this year. Walgreen, Others Offer Free HIV Tests in CDC Pilot (Reuters): Several Walgreen and other pharmacies are offering free and fast HIV tests under a $1.2 million pilot program funded by the Centers for Disease Control and Prevention, which aims to use lessons learned from testing to establish a model for detecting the virus. FDA Hearing to Focus on Replacement Hips (New York Times): Better monitoring of all-metal substitute hips will be discussed during the two-day meeting following thousands of premature failures. Shark Oil for HIV Shot Takes Cue From Hemingway's Old Man (Bloomberg News): Novartis's shark liver oil boosting agent is being added to Sanofi's ALVAC vaccine in an attempt to maintain immunity longer. New Rules Will Ban ER Debt Collections at Charitable Hospitals (Kaiser Health News/NPR): The U.S. Treasury released proposed new rules required by the 2010 health-care-overhaul law to guard patients against aggressive debt collection by nonprofit hospitals. Doctors Should Screen All Adults for Obesity, U.S. Panel Says (Time's Healthland blog): The U.S. Preventive Services Task Force recommended in the Annals of Internal Medicine that doctors measure all adults' body mass index during physicals. -For continuously updated news from The Wall Street Journal, see at

Stock News for Novartis (NVS)
11/25/201511:30:00Prescription Skin Drugs Explode in Costs, Study Shows
11/23/201509:20:02The FDA Approves Exelixis, Inc's New Cancer Drug
11/23/201508:46:033 Dividend Stocks You Don't Have to Babysit
11/20/201517:35:00Novartis Finalizes Settlement With Justice Department
11/20/201508:41:03How 1 Specialty-Drug Maker Hopes to Win Back Investor Trust
11/19/201509:16:045 Things GlaxoSmithKline PLC Wants You to Know
11/17/201511:40:56Why Ophthotech Corporation's Shares Soared in October
11/07/201513:40:09Momenta Slowed (Temporarily)
11/06/201512:16:03Why XOMA Shares Are Crashing
11/04/201510:20:02Is This Drug Going to Be a Big Threat to Biogen and Novartis...
11/01/201511:23:035 Healthcare Trends to Invest in for the Next 20 Years
10/31/201509:21:03Generic Copaxone Isn't Derailing Teva Pharmaceuticals...Yet
10/29/201516:07:02GlaxoSmithKline's Diverging Q3 Results Imply a Long Road to Recovery
10/28/201509:20:00GlaxoSmithKline Sees Higher Sales
10/28/201509:03:00GlaxoSmithKline Sees Higher Sales in Third Quarter But Lower...
10/27/201511:15:00Novartis Profit Hurt by U.S. Settlement -- 4th Update
10/27/201507:49:00Novartis Profit Hurt by U.S. Settlement-- Third Update
10/27/201505:50:00Global Stocks Fall Ahead of Fed Meeting
10/27/201505:05:00Novartis Profit Hurt by U.S. Settlement -- 2nd Update
10/27/201504:57:00Novartis Profit Hurt by U.S. Settlement -- Update

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations